Covered recipient · General Payments record
CAROLINE F KANE-CIVITANO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$1,192.93
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $346.40 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $138.72 | 8 |
| Novo Nordisk AS | $68.02 | 3 |
| PFIZER INC. | $61.47 | 3 |
| GlaxoSmithKline, LLC. | $34.21 | 2 |
| Acerta Pharma LLC | $23.30 | 1 |
| Janssen Pharmaceuticals, Inc | $20.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $23.30 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104427935 | CMS |
| GlaxoSmithKline, LLC. | $15.52 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116629872 | CMS |
| GlaxoSmithKline, LLC. | $18.69 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116698879 | CMS |
| Janssen Pharmaceuticals, Inc | $20.68 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077949038 | CMS |
| Lilly USA, LLC | $11.70 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135578562 | CMS |
| Lilly USA, LLC | $21.16 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135589863 | CMS |
| Lilly USA, LLC | $25.86 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135599893 | CMS |
| Lilly USA, LLC | $23.44 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135616529 | CMS |
| Lilly USA, LLC | $11.22 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135578564 | CMS |
| Lilly USA, LLC | $23.78 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135616531 | CMS |
| Lilly USA, LLC | $6.03 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135616533 | CMS |
| Lilly USA, LLC | $15.53 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135543657 | CMS |
| Novo Nordisk Inc | $20.87 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100630489 | CMS |
| Novo Nordisk Inc | $25.72 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100546696 | CMS |
| Novo Nordisk Inc | $21.43 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100240308 | CMS |
| PFIZER INC. | $17.94 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131261338 | CMS |
| PFIZER INC. | $28.83 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131682267 | CMS |
| PFIZER INC. | $14.70 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131079067 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.